Cantor Fitzgerald set a $65.00 target price on AVITA Med Ltd/S (OTCMKTS:AVMXY) in a research report report published on Thursday, September 20th. The brokerage currently has a buy rating on the medical device company’s stock.
Shares of OTCMKTS AVMXY traded up $0.18 during mid-day trading on Thursday, hitting $1.65. 188,068 shares of the stock traded hands, compared to its average volume of 80,825. AVITA Med Ltd/S has a 52 week low of $0.75 and a 52 week high of $2.15.
AVITA Med Ltd/S Company Profile
See Also: Trading Strategy Methods and Types
Receive News & Ratings for AVITA Med Ltd/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AVITA Med Ltd/S and related companies with MarketBeat.com's FREE daily email newsletter.